For activists who hand out clean syringes and HIV tests outside a shop in northern Moscow, the reaction from some of the area's users of injected drugs has become routine: they avert their eyes, either in fear or shame, and quicken their steps to get out of sight.
David Garmaise opens his commentary with an accurate observation: He had a misperception. But he arrives at a conclusion that is wrong. The consequences of the new funding model were not, in fact, unanticipated.
In September 2012, as part of the overall transformation of the Global Fund, the incoming new chief financial officer Daniel Camus also took up the challenge of reforming the Fund’s financial management. Over the past 18 months, he has led a growing team of financial experts whose work has now touched nearly all aspects of the Global Fund’s operations.
Eastern Europe/Central Asia advocacy group seeks Global Fund support to push national financing of HIV treatment
A regional network of people living with HIV (EUCO) on 1 May submitted an expression of interest in applying for Global Fund support for advocacy to encourage governments across Eastern Europe and Central Asia to commit to paying for anti-retroviral therapy (ART) and other treatment for HIV.
A motorcycle bouncing along a rutted red dirt road carries a nurse from a public health center near the village of Tai. Clutched in his arms is a box packed with vaccines: a month's supply for his village that sits close to the Liberian border, in Côte d'Ivoire's restive and fractious west.
The Board of the Global Fund on 25 April approved renewal and interim funding of up to $310 million. These announcements do not represent additional resources but rather reflect the country allocations announced on 12 March.
Global Fund partners in eastern and southern Africa have resolved to undertake robust country dialogues and advocate for an increase in domestic financing to boost the fight against HIV, tuberculosis and malaria.
For nearly a decade, China was one of the largest recipients of grants from the Global Fund for its fight against AIDS, TB and malaria. From 2003-2012, more than $805 million was disbursed to support 15 grants, nearly half of which (46%) contributed to prevention, diagnosis and treatment campaigns for TB across the country.
The Global Fund expects Ukraine to do more with less.
The Global Fund is telling countries whose 2014–2016 allocations consisted of only enough money to cover the costs of their existing grants that the money they are receiving has to last until the end of 2017.
The Fund is also telling all countries not to expect to receive any new funding from the 2017-2019 allocation period until the end of 2017.